| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/25/2004 | EP1390516A1 Novel expression vectors and uses thereof |
| 02/25/2004 | EP1390505A2 Antigens of group b streptococcus and corresponding dna fragments |
| 02/25/2004 | EP1390502A2 Interferon-alpha induced gene |
| 02/25/2004 | EP1390481A2 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT) |
| 02/25/2004 | EP1390478A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 02/25/2004 | EP1390468A2 Identification of essential genes of aspegillus fumigatus and methods of use |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390400A2 Pharmaceutical use for secreted bacterial effector proteins |
| 02/25/2004 | EP1390399A2 Long lasting fusion peptide inhibitors for hiv infection |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390383A1 Antisense permeation enhancers |
| 02/25/2004 | EP1390378A1 Pharmaceutically active uridine esters |
| 02/25/2004 | EP1390377A1 Crystal forms of azithromycin |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/25/2004 | EP1390361A2 Melanocortin receptor ligands |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390348A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors |
| 02/25/2004 | EP1390345A1 Polythiourea lipid derivatives |
| 02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
| 02/25/2004 | EP1390071A2 Symbiotic regenerative agent |
| 02/25/2004 | EP1390068A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists |
| 02/25/2004 | EP1390066A2 Vaccine composition |
| 02/25/2004 | EP1390063A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1390056A2 Glycopeptide antibiotics |
| 02/25/2004 | EP1390053A2 Hcg formulation |
| 02/25/2004 | EP1390047A1 Taste masking pharmaceutical composition |
| 02/25/2004 | EP1390031A2 Topical composition containing a fungicide |
| 02/25/2004 | EP1390029A1 Phenylindoles for the treatment of hiv |
| 02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
| 02/25/2004 | EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions |
| 02/25/2004 | EP1390011A2 Control of compactability through crystallization |
| 02/25/2004 | EP1389970A2 Compositions and methods of double-targeting virus infections and cancer cells |
| 02/25/2004 | EP1389909A1 Antimicrobial compounds and methods for their use |
| 02/25/2004 | EP1292293B1 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1235833B1 Analogs of (1s, cis)-4-(2-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral |
| 02/25/2004 | EP1220868B1 Extracorporeal endotoxin removal method |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1206469B1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1135481B1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 02/25/2004 | EP1049378B1 An antimicrobial composition |
| 02/25/2004 | EP1025114B1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
| 02/25/2004 | EP0984967B1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478090A Substituted imidazopyridines |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478086A Process for crystallization of(R)-or(S)-lansoprazole |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1477973A Split enveloped virus preparation |
| 02/25/2004 | CN1477972A Method for botaining antigenic aggregates and use thereof in formulations |
| 02/25/2004 | CN1477971A Split enveloped virus preparation for intranasal delivery |
| 02/25/2004 | CN1477970A 疫苗 Vaccine |
| 02/25/2004 | CN1477967A Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1477192A Recombinant pseudo-rabies virus expressing swine parvovirus VP2 gene and vacine and its preparation method |
| 02/25/2004 | CN1477128A Preparation method of specific IgY for resisting respiratory tract infection and its compound preparation |
| 02/25/2004 | CN1477127A Anti-venerism specific compound vitelline antibody and its application for curing venerism |
| 02/25/2004 | CN1477101A Purification method of Ganbaosu |
| 02/25/2004 | CN1476898A Compound skeleton tablet capable of prolonging release after oral administrationi for curing common cold |
| 02/25/2004 | CN1476895A Avermectin or ivermectin and sheep clostridial disease vacine mixed preparation |
| 02/25/2004 | CN1476894A SARS epidemic lung tissue cytoplasmic bacterium purified and refined series vacine and its production method |
| 02/25/2004 | CN1476890A Chinese medicine composition for curing child common cold fever |
| 02/25/2004 | CN1476876A Medicine for curing chronic hepatitis and hepatcirrhosis |
| 02/25/2004 | CN1476871A (Quick-acting) lijinxiao |
| 02/25/2004 | CN1476867A Freeze-dried garlic powder preparation and its preparation method |
| 02/25/2004 | CN1476852A Preparation method of Chinese medicine and its quality control method |
| 02/25/2004 | CN1476848A Preparation process of medicine capsule for curing common cold |
| 02/25/2004 | CN1476839A Gardenia total glycoside composite for curing hepatitis and its preparation method |
| 02/25/2004 | CN1476836A Anti-SARS action of zizhuisongguo chrysanthemum extract and its medicine composition |
| 02/25/2004 | CN1476831A Biphenyl double-ester solid slowly-releasing composite |
| 02/25/2004 | CN1139597C Preparation of 9-[ 2-[ [ [di (trimethylacetoxyl) methyl] phosphoros]-methoxy-ethyl] adenine |
| 02/25/2004 | CN1139596C Crystalline amine salt of cefdinir |
| 02/25/2004 | CN1139592C Camptothecin derivatives its preparing and use and midbody |
| 02/25/2004 | CN1139588C Novel fluorinated imidazoline benzodioxane, preparation and therapeutic use thereof |
| 02/25/2004 | CN1139399C Chinese Medicine pill for treating hepatitis B and its preparing method |
| 02/25/2004 | CN1139381C Application of torreyaester in resisting HIV |
| 02/24/2004 | US6697668 Ocular iontophoretic device and method for using the same |
| 02/24/2004 | US6696498 2-cyclopenten-1-one and its derivatives as inhibitors of the NF-kB factor |
| 02/24/2004 | US6696495 Treatment of disorders secondary to organic impairments |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696455 Nitrogen compounds such as 6-chloro-2-methyl-4-oxo-pyrido (3,2-d)pyrimidine used as anticarcinogenic agents and/or for prophylaxis of infections caused by pneumocystis or toxoplasma |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696451 Dihydropyrimidines |
| 02/24/2004 | US6696446 Benzoylpyridazines, their preparation and use |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
| 02/24/2004 | US6696427 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 02/24/2004 | US6696422 Parenterally administering product r, a peptide-nucleic acid preparation, in combination with one or more antiviral agents useful for treating aids or hiv infections including hiv protease inhibitors and nucleosides |
| 02/24/2004 | US6696412 Purification of daptomycin by binding to ion exchange resins in the presence of buffers and chaotropic agents, then eluting and recovering; peptide antibiotics |
| 02/24/2004 | US6696268 Production and use of antimicrobial agents |
| 02/24/2004 | US6696094 Herbal pharmaceutical composition for treatment of HIV/AIDS patients |
| 02/24/2004 | US6696076 Administering imidazoquinoline amine or imidazopyridine amine as interleukin and cytokine inhibitor |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |